Plain-English translation of NCT05847166 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new imaging scan called [99mTc]Tc-PSMA-T4 to help doctors better find prostate cancer that may have spread to lymph nodes or bones. The scan works by injecting a radioactive tracer into your bloodstream that highlights cancer cells, then taking detailed pictures. Researchers want to see if this new scan is safe and works better than standard imaging tests.
Current imaging methods sometimes miss small areas of prostate cancer spread, which can affect treatment decisions and outcomes. This study aims to find out whether this new imaging approach can detect cancer in more places and help doctors catch the disease earlier.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you will receive the new imaging scan (PSMA-T4) along with standard imaging tests like MRI, CT scans, and bone scans. The radioactive tracer is injected into your vein, and then you lie still for imaging scans that take pictures to show where cancer cells are located. The study involves visits to the hospital or imaging center for these scans, with visits spaced to allow the tracer to work properly.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Poland